Sage Journals: Discover world-class research

Open access

Research article

First published 2018-10

Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement

Helen Yu, Hoa Truong, Scott A. Mitchell [...]

Journal of Biomolecular Screening

Open access

Review article

First published 2024

Optimal use of BTK inhibitors in Waldenström’s macroglobulinemia: combination or single drug approach?

Eirini Solia, Efstathios Kastritis

Therapeutic Advances in Hematology

Free access

Research article

First published 2013-9

Development of a Pharmacodynamic Assay Based on PLCγ2 Phosphorylation for Quantifying Spleen Tyrosine Kinase (SYK)–Bruton’s Tyrosine Kinase (BTK) Signaling

Jonathan Hsu, Jun Zhang, Chris Kitson [...]

Journal of Biomolecular Screening

Free access

Research article

First published 2020-5

Nonclinical Safety Assessment of Zanubrutinib: A Novel Irreversible BTK Inhibitor

Cuining Zhang, Baohong Tian

International Journal of Toxicology

Open access

Brief report

First published 2024

Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsy

Afsaneh Shirani, Nil Saez-Calveras, Jack P. Antel [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2025

Thymoquinone’s Role in Suppressing Platelet-Mediated Migration and Epithelial to Mesenchymal Transition in MDA-MB231 Cells: Mechanistic Involvement of Btk Signaling

Nidhal Ben Amor, Sana Belkahla, Fahad Abdullah Al-Hizab [...]

Integrative Cancer Therapies

Open access

Research article

First published 2021

Current and novel BTK inhibitors in Waldenström’s macroglobulinemia

Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Despina Fotiou [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2022

Selecting the optimal BTK inhibitor therapy in CLL: rationale and practical considerations

Alexandra R. Lovell, Nadya Jammal, Prithviraj Bose

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2007-12

A FLIPR-Based Assay to Assess Potency and Selectivity of Inhibitors of the TEC Family Kinases Btk and Itk

John Douhan, Joy S. Miyashiro, Xiaochuan Zhou [...]

ASSAY and Drug Development Technologies

Open access

Review article

First published 2020

BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naïve elderly patients with CLL

Andrew Rogers, Jennifer A. Woyach

Therapeutic Advances in Hematology

Search results